As of end-2019, Eli Lilly had the highest ROE of all top publicly traded pharma companies worldwide at 319.1 percent, followed by Amgen with an 81.1 percent ROE. This statistic shows the global top publicly traded pharmaceutical companies' return on equity as of December 2019.
Global leading pharmaceutical companies' return on equity as of 2019
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Website (expresspharma.in). (June 18, 2020). Global leading pharmaceutical companies' return on equity as of 2019 [Graph]. In Statista. Retrieved September 01, 2024, from https://www.statista.com/statistics/1093262/global-pharmaceutical-companies-roe/
Website (expresspharma.in). "Global leading pharmaceutical companies' return on equity as of 2019." Chart. June 18, 2020. Statista. Accessed September 01, 2024. https://www.statista.com/statistics/1093262/global-pharmaceutical-companies-roe/
Website (expresspharma.in). (2020). Global leading pharmaceutical companies' return on equity as of 2019. Statista. Statista Inc.. Accessed: September 01, 2024. https://www.statista.com/statistics/1093262/global-pharmaceutical-companies-roe/
Website (expresspharma.in). "Global Leading Pharmaceutical Companies' Return on Equity as of 2019." Statista, Statista Inc., 18 Jun 2020, https://www.statista.com/statistics/1093262/global-pharmaceutical-companies-roe/
Website (expresspharma.in), Global leading pharmaceutical companies' return on equity as of 2019 Statista, https://www.statista.com/statistics/1093262/global-pharmaceutical-companies-roe/ (last visited September 01, 2024)
Global leading pharmaceutical companies' return on equity as of 2019 [Graph], Website (expresspharma.in), June 18, 2020. [Online]. Available: https://www.statista.com/statistics/1093262/global-pharmaceutical-companies-roe/